ADOLOR
Adolor Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of prescription pain and pain-management products. ENTEREG (alvimopan) is the United States Food and Drug Administration (FDA) approved product. ENTEREG is indicated to accelerate upper and lower gastrointestinal (GI) recovery following partial large or small bowel resection surgery with primary anastomosis. The Company is conducting two Phase 2 clinical trials of ADL5945 to treat opioid... -induced constipation (OIC), a condition that often results from long-term use of opioid analgesics in the management of chronic pain conditions. In addition, it is continuing development efforts on ADL7445, a second peripherally-acting mu opioid receptor antagonist, which is considered a back-up compound in its OIC program. The Company has completed Phase 1 clinical evaluation of ADL6906 (beloxepin).
ADOLOR
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
1993-01-01
Address:
Exton, Pennsylvania, United States
Country:
United States
Website Url:
http://www.adolor.com
Total Employee:
51+
Status:
Closed
Contact:
17818601407
Technology used in webpage:
Domain Not Resolving Tierpoint
Similar Organizations
AcSentient
AcSentient develops and commercializes specialty, niche prescription drugs.
Fedora Pharmaceuticals
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
Insero Health
Insero Health is involved in the discovery, development and commercialization of pharmaceuticals for epilepsy and related conditions.
Kentucky Bioprocessing
Kentucky Bioprocessing is a global leader in the expression, extraction, and commercialization of proteins and other plant-derived products.
Laboratorios Gebro Pharma
Laboratorios Gebro Pharma is focuses on the development and commercialization of treatments against pain and inflammation.
Lucideon
Lucideon is a development and commercialization organization (DCO), specializing in materials technologies and processes
Photoelectron
Engaged in the design, development and commercialization of the Photon Radiosurgery System.
RareGen
RareGen provides strategy, investment, and commercialization for rare disease pharmaceutical products.
Receptos
Receptos focuses on the discovery, development and commercialization of various therapeutics for immune disorders.
Salient Pharmaceuticals
Salient is developing CASAD™, a proprietary composition proven to adsorb a range of toxins and inflammatory proteins.
Current Advisors List
Current Employees Featured
